BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35400231)

  • 1. Differential Expression of Secretogranins II and III in Canine Adrenal Chromaffin Cells and Pheochromocytomas.
    Gomi H; Nagumo T; Asano K; Konosu M; Yasui T; Torii S; Hosaka M
    J Histochem Cytochem; 2022 May; 70(5):335-356. PubMed ID: 35400231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma.
    Guérin M; Guillemot J; Thouënnon E; Pierre A; El-Yamani FZ; Montero-Hadjadje M; Dubessy C; Magoul R; Lihrmann I; Anouar Y; Yon L
    Regul Pept; 2010 Nov; 165(1):21-9. PubMed ID: 20600356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66.
    Guillemot J; Thouënnon E; Guérin M; Vallet-Erdtmann V; Ravni A; Montéro-Hadjadje M; Lefebvre H; Klein M; Muresan M; Seidah NG; Anouar Y; Yon L
    J Mol Endocrinol; 2012 Apr; 48(2):115-27. PubMed ID: 22217803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretogranin III in human neuroendocrine tumours: a comparative immunohistochemical study with chromogranins A and B and secretogranin II.
    Portela-Gomes GM; Grimelius L; Stridsberg M
    Regul Pept; 2010 Nov; 165(1):30-5. PubMed ID: 20550951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the secretogranin II-derived peptide EM66 in pheochromocytomas as a potential marker for discriminating benign versus malignant tumors.
    Yon L; Guillemot J; Montero-Hadjadje M; Grumolato L; Leprince J; Lefebvre H; Contesse V; Plouin PF; Vaudry H; Anouar Y
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2579-85. PubMed ID: 12788858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas An immunohistochemical study with region-specific antibodies.
    Portela-Gomes GM; Stridsberg M; Grimelius L; Falkmer UG; Falkmer S
    APMIS; 2004 Oct; 112(10):663-73. PubMed ID: 15601318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary adenylate cyclase-activating polypeptide stimulates secretoneurin release and secretogranin II gene transcription in bovine adrenochromaffin cells through multiple signaling pathways and increased binding of pre-existing activator protein-1-like transcription factors.
    Turquier V; Yon L; Grumolato L; Alexandre D; Fournier A; Vaudry H; Anouar Y
    Mol Pharmacol; 2001 Jul; 60(1):42-52. PubMed ID: 11408599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and processing of the neuroendocrine protein secretogranin II in benign and malignant pheochromocytomas.
    Guillemot J; Barbier L; Thouennon E; Vallet-Erdtmann V; Montero-Hadjadje M; Lefebvre H; Klein M; Muresan M; Plouin PF; Seidah N; Vaudry H; Anouar Y; Yon L
    Ann N Y Acad Sci; 2006 Aug; 1073():527-32. PubMed ID: 17102121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal chromogranins and secretogranins are increased in patients with ulcerative colitis but are not associated with disease activity.
    Strid H; Simrén M; Lasson A; Isaksson S; Stridsberg M; Öhman L
    J Crohns Colitis; 2013 Dec; 7(12):e615-22. PubMed ID: 23694857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical staining of human islet cells with region-specific antibodies against secretogranins II and III.
    Stridsberg M; Grimelius L; Portela-Gomes GM
    J Anat; 2008 Mar; 212(3):229-34. PubMed ID: 18221483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromogranin A, secretogranin II and vasoactive intestinal peptide in phaeochromocytomas and ganglioneuromas.
    Schmid KW; Dockhorn-Dworniczak B; Fahrenkamp A; Kirchmair R; Tötsch M; Fischer-Colbrie R; Böcker W; Winkler H
    Histopathology; 1993 Jun; 22(6):527-33. PubMed ID: 8354485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of chromogranins A, B, and secretogranin II in human adrenal medulla and pheochromocytoma.
    Schober M; Fischer-Colbrie R; Schmid KW; Bussolati G; O'Connor DT; Winkler H
    Lab Invest; 1987 Oct; 57(4):385-91. PubMed ID: 3669614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of connexins in chromaffin cells of normal human adrenals and in benign and malignant pheochromocytomas.
    Willenberg HS; Schott M; Saeger W; Tries A; Scherbaum WA; Bornstein SR
    Ann N Y Acad Sci; 2006 Aug; 1073():578-83. PubMed ID: 17102126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyoma-induced neoplasms of the mouse adrenal medulla. Characterization of the tumors and establishment of cell lines.
    Tischler AS; Freund R; Carroll J; Cahill AL; Perlman RL; Alroy J; Riseberg JC
    Lab Invest; 1993 May; 68(5):541-9. PubMed ID: 8098784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Secretogranin III in Chicken Endocrine Cells: Its Relevance to the Secretory Granule Properties of Peptide Prohormone Processing and Bioactive Amine Content.
    Gomi H; Morikawa S; Shinmura N; Moki H; Yasui T; Tsukise A; Torii S; Watanabe T; Maeda Y; Hosaka M
    J Histochem Cytochem; 2015 May; 63(5):350-66. PubMed ID: 25673289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of trophic peptides and their receptors in chromaffin cells and pheochromocytoma.
    Thouennon E; Pierre A; Yon L; Anouar Y
    Cell Mol Neurobiol; 2010 Nov; 30(8):1383-9. PubMed ID: 21046451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuroendocrine proteins secretogranin II and III are regionally conserved and coordinately expressed with proopiomelanocortin in Xenopus intermediate pituitary.
    Holthuis JC; Martens GJ
    J Neurochem; 1996 Jun; 66(6):2248-56. PubMed ID: 8632145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sorting systems for secretory granules ensure the regulated secretion of peptide hormones.
    Sun M; Watanabe T; Bochimoto H; Sakai Y; Torii S; Takeuchi T; Hosaka M
    Traffic; 2013 Feb; 14(2):205-18. PubMed ID: 23171199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a chromogranin A domain that mediates binding to secretogranin III and targeting to secretory granules in pituitary cells and pancreatic beta-cells.
    Hosaka M; Watanabe T; Sakai Y; Uchiyama Y; Takeuchi T
    Mol Biol Cell; 2002 Oct; 13(10):3388-99. PubMed ID: 12388744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretogranin II: regulation of synthesis and post-translational proteolysis in bovine adrenal chromaffin cells.
    Soszynski D; Metz-Boutigue MH; Aunis D; Bader MF
    J Neuroendocrinol; 1993 Dec; 5(6):655-62. PubMed ID: 8680438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.